Literature DB >> 9692710

Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons.

R C Dodel1, Y Du, K R Bales, Z D Ling, P M Carvey, S M Paul.   

Abstract

Multiple aspartate-specific cysteine proteases have been identified and specific members of this family have been implicated in the apoptotic death of many mammalian cell types. Caspase-3-like proteases seem to play a pivotal role in neuronal apoptosis since mice with germline inactivation of the caspase-3 gene manifest profound alterations in neurogenesis. Moreover, inhibitors of caspase-3-related proteases have been shown to inhibit neuronal apoptosis. Here we extend recent work from our laboratory on the mechanisms mediating the neurotoxic actions of 1-methyl-4-phenylpyridinium using ventral mesencephalon cultures containing dopamine neurons. We demonstrate that low concentrations of 1-methyl-4-phenylpyridinium induce apoptosis in dopamine neurons by morphological and biochemical criteria. Moreover, pretreatment of ventral mesencephalon cultures with the tetrapeptide inhibitors of the caspase-3-like proteases zVAD-FMK or Ac-DEVD-CHO specifically inhibit death of dopamine neurons induced by low concentrations of 1-methyl-4-phenylpyridinium, whereas the caspase-1-like inhibitor Ac-YVAD-CHO was without effect. Our data indicate that exposure of cultured ventral mesencephalon dopamine neurons to low concentrations of 1-methyl-4-phenylpyridinium results in apoptotic death and that caspase-3-like proteases may mediate the neurotoxic apoptotic actions of 1-methyl-4-phenylpyridinium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692710     DOI: 10.1016/s0306-4522(98)00154-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

1.  Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.

Authors:  A Hartmann; J D Troadec; S Hunot; K Kikly; B A Faucheux; A Mouatt-Prigent; M Ruberg; Y Agid; E C Hirsch
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

2.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

Authors:  A Hartmann; S Hunot; P P Michel; M P Muriel; S Vyas; B A Faucheux; A Mouatt-Prigent; H Turmel; A Srinivasan; M Ruberg; G I Evan; Y Agid; E C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.

Authors:  V Viswanath; Y Wu; R Boonplueang; S Chen; F F Stevenson; F Yantiri; L Yang; M F Beal; J K Andersen
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

4.  Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells.

Authors:  Charleen T Chu; Jian-hui Zhu; Guodong Cao; Armando Signore; Suping Wang; Jun Chen
Journal:  J Neurochem       Date:  2005-09       Impact factor: 5.372

Review 5.  Apoptotic cell death regulation in neurons.

Authors:  Emilie Hollville; Selena E Romero; Mohanish Deshmukh
Journal:  FEBS J       Date:  2019-07-12       Impact factor: 5.542

6.  Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.

Authors:  S Samantaray; V H Knaryan; C Le Gal; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

7.  Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

Authors:  Y Du; Z Ma; S Lin; R C Dodel; F Gao; K R Bales; L C Triarhou; E Chernet; K W Perry; D L Nelson; S Luecke; L A Phebus; F P Bymaster; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

8.  GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neurons.

Authors:  Eun S Chung; Eugene Bok; Sunghyang Sohn; Young D Lee; Hyung H Baik; Byung K Jin
Journal:  BMC Neurosci       Date:  2010-06-12       Impact factor: 3.288

9.  1-Methyl-4-phenylpyridinium induces synaptic dysfunction through a pathway involving caspase and PKCdelta enzymatic activities.

Authors:  Yafell Serulle; Gerardo Morfini; Gustavo Pigino; Jorge E Moreira; Mutsuyuki Sugimori; Scott T Brady; Rodolfo R Llinás
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-07       Impact factor: 11.205

10.  Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.

Authors:  Minho Moon; Hyo Geun Kim; Lakkyong Hwang; Ji-Hyung Seo; Sehee Kim; Sunyoung Hwang; Soonyong Kim; Dahm Lee; Hyunju Chung; Myung Sook Oh; Kyung-Tae Lee; Seungjoon Park
Journal:  Neurotox Res       Date:  2009-03-17       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.